Amount of High Mobility Group Box protein-1Produced by Inflamed Microgelial cell line, BV-2, Under the Effect of Glycyrrhizin Component of Glycyrrhiza glabra (Licorice)

Authors
Akram Aminian 1
Farshid Hamidi 1
Hadi Mohebalian 2
1 Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran
2 Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran
Abstract
Introduction

Glycyrrhiza glabra is a plant used in traditional medicine across the world for its pharmacological value. Its value has been proved such as anti-cough, anti-diabetes, anti-microbial and antioxidant effects.

Materials and Methods

In this study the effect of a glycyrrhizin component of HMGB1's microglia product becomes in the survey, at terms of informative mediating on in vitro modeling that have six groups (with three replications). In negative control group no Gly and LPS was involved. In positive control group, the cells were induced with LPS and no Gly, and in 3, 4, 5 and 6 groups 0.2, 0.4, 1.2 and 4 µg/ml Gly were added respectively. The amounts of HMGB1 were measured at 24, 48 and 72 hours with the sandwich ELISA kit.

Results

At all three times, the HMGB1 were decreased with increasing Gly, but in 24 h between 0.2 and 1.2 concentrations and in 72 h between positive control and 0.2 no significant difference were found. So it is concluded that this amount should be increased for the effective dose.

Conclusion

Along with previous studies, Glycyrrhizin reduced the production of HMGB1 in the microglial cell line.
Keywords
Glycyrrhiza glabra
HMGB1 protein
glycyrrhizin
Microglial cell
1. Vaez zadeh F. Iranian Slavic forms and comparison of its active ingredients. Dissertation, Faculty of Pharmacy, University of Tehran; 1342. [In Persian].
2. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006 Dec 1;46(3):167-92.
3. Lesani Khoshnik. Types of Licorice Plant in Iran and their location, Dissertation, Faculty of Pharmacy University Tehran; 1341. [In Persian].
4. Fenwick GR, Lutomski J, Nieman C. Liquorice, Glycyrrhiza glabra L.—Composition, uses and analysis. Food Chem. 1990 Jan 1;38(2):119-43.
5. Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol. 2005 Jul 14;99(3):317-24.
6. Feng X, Ding L, Qiu F. Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid. Drug Metab Rev. 2015 May;47(2):229-38.
7. Charpe TW, Rathod VK. Extraction of glycyrrhizic acid from licorice root using ultrasound: process intensification studies. Chem. Eng. Process. 2012 Apr 30;54:37-41.
8. Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 2008 Jun 1;22(6):709-24.
9. Yu JY, Ha JY, Kim KM, Jung YS, Jung JC, Oh S. Anti-inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules. 2015 Jul 20;20(7):13041-54.
10. Song JH, Lee JW, Shim B, Lee CY, Choi S, Kang C, Sohn NW, Shin JW. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules. 2013 Dec 17;18(12):15788-803.
11. Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Mol Aspects Med. 2014 .40:1-116.
12. Reeves R. Nuclear functions of the HMG proteins. Biochim Biophys Acta Gene Regul Mech. 2010 .1799(1):3-14.
13. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002 Jul 11;418(6894):191-5.
14. Antoine DJ, Jenkins RE, Dear JW, Williams DP et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol. 2012 May;56(5):1070-9.
15. Bianchi ME. HMGB1 loves company. J Leukoc Biol. 2009;86(3):573-6.
16. Gong G, Yuan L-b, Hu L, Wu W, Yin L, Hou J-l, et al. Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1. Acta Pharmacol. Sin. 2012 .33(1):11.
17. Xiang K, Cheng L, Luo Z, Ren J, Tian F, Tang L, et al. Glycyrrhizin suppresses the expressions of HMGB1 and relieves the severity of traumatic pancreatitis in rats. PloS one. 2014.9(12):e115982.
18. Lau A, Wang S, Liu W, Haig A, Zhang Z-X, Jevnikar AM. Glycyrrhizic acid ameliorates HMGB1-mediated cell death and inflammation after renal ischemia reperfusion injury. Am J Nephrol. 2014.40(1):84-95.
19. Beier EE, Neal M, Alam G, Edler M, Wu L-J, Richardson JR. Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis. 2017.:115-27.
20. Shen L, Cui Z, Lin Y, Wang S, Zheng D, Tan Q. Anti-inflammative effect of glycyrrhizin on rat thermal injury via inhibition of high-mobility group box 1 protein. Burns.41(2):372-8.
21. Man L-l, Liu F, Wang Y-j, Song H-h, Xu H-b, Zhu Z-w, et al. The HMGB1 signaling pathway activates the inflammatory response in Schwann cells. Neural Regen. Res. 2015. 10(10):1706.
22. Thakur V, Nargis S, Gonzalez M, Pradhan S, Terreros D, Chattopadhyay M. Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease. Nephron. 2017 .137(2):137-47.
23. Xiong X, Gu L, Wang Y, Luo Y, Zhang H, Lee J, et al. Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms. J NEUROINFLAMM. 2016 .13(1):241.
24. Chen X, Fang D, Li L, Chen L, Li Q, Gong F, et al. Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells. Immunol res. 2017 .65(3):666-80.
25. Bellussi LM, Vindigni C, Cocca S, Butorano MAGM, Livi W, Corallo G, et al. High-mobility group box protein 1 expression in inflammatory diseases of the middle ear. Int J Immunopathol Pharmacol. 2017 .30(2):168-73.
26. Zhao F, Fang Y, Deng S, Li X, Zhou Y, Gong Y, et al. Glycyrrhizin protects rats from sepsis by blocking HMGB1 signaling. BioMed research international. Biomed Res Int. 2017. 9119647.
27. Zhang H, Zhang R, Chen J, Shi M, Li W, Zhang X. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats. Kidney Blood Press Res. 2017 .42(5):894-904.
28. Okuma Y, Liu K, Wake H, Liu R, Nishimura Y, Hui Z, et al. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction. Neuropharmacology. 2014 .85:18-26.
29. Gao T, Chen Z, Chen H, Yuan H, Wang Y, Peng X, et al. Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization. Biochem Biophys Res Commun. 497(1):430-6.
30. Angelopoulou E, Piperi C, Papavassiliou AG. High-mobility Group Box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches. J NEUROCHEM. 2018. 146(3):211-218.
31. Rafiei N, Hamidi F, Mohebalian H. Effects of Glycyrrhizin Component of Licorice on NO Production by Lipopolyssacharide- induced Microglial cell line, BV-2. The national Conference on Herbal Drugs in Veterinary Medicine. 2017. [In Persian]
32. Aghighi O, Hamidi F, Mohebalian H. Effects of Glycyrrhizin Component of Licorice on IL-6 Production by Lipopolyssacharide- stimulated Microglial cell line, BV-2. The International Conference on Agricultural Science Medicinal Plants Traditional Medicine. 2018. [In Persian]
33. Dehghani K, Hamidi F, Mohebalian H. Effects of Glycyrrhizin Component of Licorice on IL-1β Production by Lipopolyssacharide-stimulated Microglial cell line, BV-2. The International Conference on Agricultural Science Medicinal Plants Traditional Medicine. 2018. [In Persian]
34. Azarakhsh M, Hamidi F, Mohebalian H. P13: Anti-Inflammatory Effect of Glycyrrhizin on TNF-α Produced by Inflamed Microglia Cell (BV-2). Neurosci J Shefaye Khatam. 2018; 6 (S1) :44-44.